Antibe Therapeutics Inc (ATBPF)
0.2156
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Antibe Therapeutics Max Drawdown (5Y): 97.99% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 97.99% |
| March 31, 2024 | 95.11% |
| February 29, 2024 | 95.11% |
| January 31, 2024 | 95.11% |
| December 31, 2023 | 95.11% |
| November 30, 2023 | 95.11% |
| October 31, 2023 | 95.11% |
| September 30, 2023 | 95.11% |
| August 31, 2023 | 95.11% |
| July 31, 2023 | 95.11% |
| June 30, 2023 | 95.11% |
| May 31, 2023 | 95.11% |
| April 30, 2023 | 95.11% |
| March 31, 2023 | 95.11% |
| February 28, 2023 | 95.11% |
| January 31, 2023 | 95.11% |
| December 31, 2022 | 95.11% |
| November 30, 2022 | 93.98% |
| October 31, 2022 | 93.43% |
| September 30, 2022 | 92.36% |
| August 31, 2022 | 92.17% |
| July 31, 2022 | 92.17% |
| June 30, 2022 | 91.93% |
| May 31, 2022 | 91.37% |
| April 30, 2022 | 91.37% |
| Date | Value |
|---|---|
| March 31, 2022 | 91.37% |
| February 28, 2022 | 91.37% |
| January 31, 2022 | 91.37% |
| December 31, 2021 | 91.37% |
| November 30, 2021 | 90.53% |
| October 31, 2021 | 88.93% |
| September 30, 2021 | 88.93% |
| August 31, 2021 | 88.93% |
| July 31, 2021 | 88.93% |
| June 30, 2021 | 88.93% |
| May 31, 2021 | 88.93% |
| April 30, 2021 | 88.93% |
| March 31, 2021 | 88.93% |
| February 28, 2021 | 88.93% |
| January 31, 2021 | 88.93% |
| December 31, 2020 | 88.93% |
| November 30, 2020 | 88.93% |
| October 31, 2020 | 88.93% |
| September 30, 2020 | 88.93% |
| August 31, 2020 | 88.93% |
| July 31, 2020 | 88.93% |
| June 30, 2020 | 88.93% |
| May 31, 2020 | 88.93% |
| April 30, 2020 | 88.93% |
| March 31, 2020 | 88.93% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
88.93%
Minimum
Dec 2019
97.99%
Maximum
Apr 2024
91.39%
Average
89.81%
Median
Max Drawdown (5Y) Benchmarks
| Acasti Pharma Inc | 98.73% |
| Aurinia Pharmaceuticals Inc | 87.58% |
| Edesa Biotech Inc | 99.58% |
| Lexaria Bioscience Corp | 98.90% |
| InMed Pharmaceuticals Inc | 99.92% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -47.53 |
| Beta (5Y) | 0.5746 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 76.40% |
| Historical Sharpe Ratio (5Y) | -0.5384 |
| Historical Sortino (5Y) | -0.796 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.55% |